[sulfobutylether-b-cyclodextrin](1).[danazol] |
2.48 |
|
|
22.0 |
phase solubility |
Moji Christianah Adeyeye 2001 |
[sulfobutylether-b-cyclodextrin](1).[danazol] |
2.20 |
|
|
37.0 |
phase solubility |
Moji Christianah Adeyeye 2001 |
[sulfobutylether-b-cyclodextrin](1).[Ebselen] |
3.43 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[sulfobutylether-b-cyclodextrin](1).[Ebselen] |
3.56 |
|
7.0 |
25.0 |
1H-NMR |
Kaneto Uekama 2002 |
[sulfobutylether-b-cyclodextrin](1).[fentanyl] |
2.86 |
|
8.0 |
|
phase solubility |
J. Plaizier-Vercammen 2003 |
[sulfobutylether-b-cyclodextrin](1).[Ziprasidone mesylate] |
2.98 |
|
3.8 |
|
CD, NMR, phase solubility |
Yesook Kim 1998 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.15 |
|
5.0 |
70.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.31 |
|
5.0 |
60.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.46 |
|
5.0 |
50.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.48 |
|
5.0 |
37.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
3.99 |
|
7.4 |
70.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.16 |
|
7.4 |
60.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.49 |
|
7.4 |
50.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[dipivefrine] |
4.81 |
|
7.4 |
37.0 |
HPLC-method |
Pekka Jarho 1997 |
[sulfobutylether-b-cyclodextrin](1).[neutral red] |
2.88 |
|
5.0 |
20.0 |
Fluorescence spectroscopy |
Shaomin Shuang 2002 |
[sulfobutylether-b-cyclodextrin](1).[neutral red] |
3.36 |
|
7.5 |
20.0 |
Fluorescence spectroscopy |
Shaomin Shuang 2002 |
[sulfobutylether-b-cyclodextrin](1).[neutral red] |
3.41 |
|
10.5 |
20.0 |
Fluorescence spectroscopy |
Shaomin Shuang 2002 |
[sulfobutylether-b-cyclodextrin](1).[chlorambucil] |
3.15 |
1.70 |
7.35 |
40.0 |
HPLC-method |
Thorsteinn Loftsson 1998 |
[sulfobutylether-b-cyclodextrin](1).[indomethacin] |
2.41 |
1.30 |
9.8 |
40.0 |
HPLC-method |
Thorsteinn Loftsson 1998 |
[sulfobutylether-b-cyclodextrin](1).[diazepam] |
1.85 |
1.78 |
2.0 |
30.5 |
HPLC-method |
Thorsteinn Loftsson 1998 |
[sulfobutylether-b-cyclodextrin](1).[naproxen] |
3.72 |
|
5.0 |
25.0 |
UV-vis spectroscopy |
P. Mura 2005 |
[sulfobutylether-b-cyclodextrin](1).[naproxen] |
3.58 |
|
5.0 |
37.0 |
UV-vis spectroscopy |
P. Mura 2005 |
[sulfobutylether-b-cyclodextrin](1).[naproxen] |
3.49 |
|
5.0 |
45.0 |
UV-vis spectroscopy |
P. Mura 2005 |
[sulfobutylether-b-cyclodextrin](1).[R-Apomorphine] |
0.21 |
|
3.0 |
25.0 |
Capillary electrophoresis |
Ann Van Schepdael 2004 |
[sulfobutylether-b-cyclodextrin](2).[R-Apomorphine] |
0.19 |
|
3.0 |
25.0 |
Capillary electrophoresis |
Ann Van Schepdael 2004 |
[sulfobutylether-b-cyclodextrin](1).[S-Apomorphine] |
0.57 |
|
3.0 |
25.0 |
Capillary electrophoresis |
Ann Van Schepdael 2004 |
[sulfobutylether-b-cyclodextrin](2).[S-Apomorphine] |
0.60 |
|
3.0 |
25.0 |
Capillary electrophoresis |
Ann Van Schepdael 2004 |
[sulfobutylether-b-cyclodextrin](1).[2,6-diisopropyl phenol] |
3.57 |
|
7.0 |
30.0 |
HPLC-method |
M.K. Manoj Babu 2004 |
[sulfobutylether-b-cyclodextrin](1).[2,6-diisopropyl phenol] |
3.57 |
|
7.0 |
37.0 |
HPLC-method |
M.K. Manoj Babu 2004 |
[sulfobutylether-b-cyclodextrin](1).[cyclosporin A] |
1.34 |
|
7.0 |
25.0 |
HPLC method |
Laura Matilainen 2006 |
[sulfobutylether-b-cyclodextrin](1).[valdecoxib] |
3.15 |
|
6.8 |
25.0 |
UV-vis spectroscopy |
Tayade Pralhad 2005 |
[sulfobutylether-b-cyclodextrin](1).[butyl-methoxydibenzoylmethane] |
3.34 |
|
7.0 |
25.0 |
HPLC-method |
Santo Scalia 2004 |
[sulfobutylether-b-cyclodextrin](2).[butyl-methoxydibenzoylmethane] |
1.08 |
|
7.0 |
25.0 |
HPLC-method |
Santo Scalia 2004 |
[sulfobutylether-b-cyclodextrin](1).[O6-benzylguanine] |
2.75 |
|
7.0 |
25.0 |
HPLC-method |
Valentino J. Stella 1995 |
[sulfobutylether-b-cyclodextrin](1).[O6-benzylguanine] |
2.53 |
|
7.0 |
50.0 |
HPLC-method |
Valentino J. Stella 1995 |
[sulfobutylether-b-cyclodextrin](1).[O6-benzylguanine] |
2.49 |
|
2.2 |
50.0 |
HPLC-method |
Valentino J. Stella 1995 |
[sulfobutylether-b-cyclodextrin](1).[O6-benzylguanine] |
2.43 |
|
4.8 |
50.0 |
HPLC-method |
Valentino J. Stella 1995 |
[sulfobutylether-b-cyclodextrin](1).[ozonide antimalarial] |
6.36 |
5.30 |
7.4 |
25.0 |
Isothermal Titration Calorimetry |
Susan A. Charman 2006 |
[sulfobutylether-b-cyclodextrin](1).[ozonide antimalarial] |
6.20 |
5.30 |
7.4 |
37.0 |
Isothermal Titration Calorimetry |
Susan A. Charman 2006 |
[sulfobutylether-b-cyclodextrin](1).[vinpocetine] |
2.53 |
|
7.0 |
21.0 |
UV-vis spectroscopy |
Francisco Veiga 2003 |
[sulfobutylether-b-cyclodextrin](1).[vinpocetine] |
2.53 |
0.90 |
7.0 |
22.0 |
UV-vis spectroscopy |
Francisco J.B. Veiga 2003 |
[sulfobutylether-b-cyclodextrin](1).[4[4-(methylsulfonyl) phenyl]-3-phenyl-2 (5H)-furazone] |
2.12 |
|
7.2 |
25.0 |
UV-vis spectroscopy |
Tayade Pralhad 2004 |
[sulfobutylether-b-cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] |
4.74 |
2.40 |
4.0 |
37.0 |
Circular dichroism |
K. Uekama 2001 |
[sulfobutylether-b-cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] |
3.71 |
2.48 |
6.0 |
37.0 |
Circular dichroism |
K. Uekama 2001 |
[sulfobutylether-b-cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] |
3.48 |
2.63 |
7.4 |
37.0 |
Circular dichroism |
K. Uekama 2001 |
[sulfobutylether-b-cyclodextrin](1).[amlodipine enantiomer(2)] |
2.78 |
1.85 |
3.95 |
17.0 |
HPLC |
Anthony F. Fell 1998 |
[sulfobutylether-b-cyclodextrin](1).[meso-tetrakis(4-N-ethylpyridiumyl) porphyrin] |
5.30 |
|
7.61 |
20.0 |
UV-vis and fluorescence spectroscopy |
Shuang Shaomin 2005 |
[sulfobutylether-b-cyclodextrin](1).[meso-tetrakis(4-N-methylpyridiumyl) porphyrin] |
4.58 |
|
7.61 |
20.0 |
UV-vis and fluorescence spectroscopy |
Shuang Shaomin 2005 |
[sulfobutylether-b-cyclodextrin](1).[prednisolone] |
3.43 |
1.79 |
5.5 |
25.0 |
NMR spectroscopy |
Kim L.Larsen 2005 |
[sulfobutylether-b-cyclodextrin](1).[prednisolone] |
3.26 |
|
|
25.0 |
UV-vis spectroscopy |
Kim L.Larsen 2005 |
[sulfobutylether-b-cyclodextrin](1).[6a-methyl prednisolone] |
2.85 |
1.28 |
5.5 |
25.0 |
NMR spectroscopy |
Kim L.Larsen 2005 |
[sulfobutylether-b-cyclodextrin](1).[6a-methyl prednisolone] |
2.86 |
|
|
25.0 |
|
Kim L.Larsen 2005 |
[sulfobutylether-b-cyclodextrin](1).[6a-methyl prednisolone] |
2.86 |
|
|
25.0 |
UV-vis spectroscopy |
Kim L.Larsen 2005 |